Home
About
Overview
Sharing Data
ORCID
Help
History (1)
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies.
COVID-19 in Patients with Multiple Sclerosis: Associations with Disease-Modifying Therapies. CNS Drugs. 2021 03; 35(3):317-330.
View in:
PubMed
subject areas
Adolescent
Adult
African Americans
Aged
Aged, 80 and over
Alemtuzumab
Azathioprine
Cladribine
Comorbidity
Crotonates
Cyclophosphamide
Cyclosporine
Databases, Factual
Dimethyl Fumarate
Female
Fingolimod Hydrochloride
Hospitalization
Humans
Hydroxybutyrates
Immunologic Factors
Immunosuppressive Agents
Incidence
Interferon-beta
Logistic Models
Lupus Erythematosus, Systemic
Male
Methotrexate
Middle Aged
Mitoxantrone
Multiple Sclerosis
Mycophenolic Acid
Natalizumab
Nitriles
Obesity
Risk Factors
Rituximab
Toluidines
United States
Young Adult
authors with profiles
Anthony T. Reder